Signaling Pathway
Imelciment is a human monoclonal antibody of the half-IgG4 subtype, featuring a kappa light chain and engineered hinge regions (h-CH2-CH3). Specifically designed to target NPR1 (Natriuretic Peptide Receptor 1), this antibody is optimized for high specificity and stability, making it a valuable tool for research into cardiovascular signaling pathways and potential therapeutic applications.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Imelciment is a human monoclonal antibody of the half-IgG4 subtype, featuring a kappa light chain and engineered hinge regions (h-CH2-CH3). Specifically designed to target NPR1 (Natriuretic Peptide Receptor 1), this antibody is optimized for high specificity and stability, making it a valuable tool for research into cardiovascular signaling pathways and potential therapeutic applications. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
